Tested batch: EP-260519-TE10
Tesamorelin is a synthetic growth hormone releasing hormone analog. Each box contains 10 vials of lyophilized powder, with 10mg per vial. This peptide is supplied as a research compound for laboratory use only.
Specifications: SKU TM10 · 10 vials of lyophilised powder per box · 10mg per vial · measured net content 11.49 mg. Testing: four Kovera Labs reports for batch EP-260519-TE10: RP-HPLC purity 99.653% with LC-MS identity, endotoxin < 0.20 EU/mL, heavy metals and sterility – see the certificates below. Further reading: Tesamorelin in Australia: product overview and Tesamorelin: a research guide to evaluating suppliers. For laboratory research use only; not for human consumption.
Free shipping on all products.
This product is strictly intended for laboratory research use only. Not for human consumption. All products sold are for research purposes and should only be handled by qualified professionals in a controlled laboratory environment.
Tested batch: EP-260519-TE10 · 4 published certificates. Report library updated .
Batch EP-260519-TE10 – four Kovera Labs reports. Purity and identity: RP-HPLC purity 99.653%, net content 11.49 mg, LC-MS identity: Tesamorelin (KVR-2026-BEC6A9, 30 June 2026). Endotoxin: < 0.20 EU/mL (ENDO-KVR-2026-BEC6A9). Heavy metals: lead < 0.5, arsenic < 0.15, cadmium < 0.05 and mercury < 0.3 ppm (HM-KVR-2026-BEC6A9). Sterility: no bacterial growth (aerobic and anaerobic) and no fungi or yeast detected after a 2-day incubation (RSTER-KVR-2026-BEC6A9). Each certificate links to its Kovera Labs verification record, and the product image shows the same batch reference. For laboratory research use only.
| Test | Reported result | Report ID | Report date |
|---|---|---|---|
| Purity and Identity (COA) | Purity: 99.653 %; Net content: 11.49 mg; Identity confirmation: Tesamorelin | KVR-2026-BEC6A9 | 30 June 2026 |
| Endotoxin | Endotoxin: < 0.20 EU/mL | ENDO-KVR-2026-BEC6A9 | 30 May 2026 |
| Heavy Metals | Lead: < 0.5 ppm; Arsenic: < 0.15 ppm; Cadmium: < 0.05 ppm; Mercury: < 0.3 ppm | HM-KVR-2026-BEC6A9 | 31 May 2026 |
| Sterility testing | Bacteria (aerobic/anaerobic): No Growth; Fungi / yeast: Not Detected; Incubation period: 2 days | RSTER-KVR-2026-BEC6A9 | 30 May 2026 |
Read how to interpret and verify a Kovera Labs report or browse our testing standards and report directory.
Verify this certificate on Kovera Labs
| Reported test | Result | Stated criterion | Method, where stated |
|---|---|---|---|
| Purity | 99.653 % | — | RP-HPLC |
| Net content | 11.49 mg | — | — |
| Identity confirmation | Tesamorelin | — | LC-MS |
| Endotoxin screen | PASS | — | — |
| Microbial sterility screen | No Growth | — | — |
| Arsenic (As) screening | Negative | — | — |
| Cadmium (Cd) screening | Negative | — | — |
| Lead (Pb) screening | Negative | — | — |
| Mercury (Hg) screening | Negative | — | — |
Verify this certificate on Kovera Labs
| Reported test | Result | Stated criterion | Method, where stated |
|---|---|---|---|
| Endotoxin | < 0.20 EU/mL | ≤ 0.5 | — |
| Final determination | PASS | — | — |
Verify this certificate on Kovera Labs
| Reported test | Result | Stated criterion | Method, where stated |
|---|---|---|---|
| Lead | < 0.5 ppm | ≤ 10 | ICP-MS |
| Arsenic | < 0.15 ppm | ≤ 1.5 | ICP-MS |
| Cadmium | < 0.05 ppm | ≤ 0.5 | ICP-MS |
| Mercury | < 0.3 ppm | ≤ 3 | ICP-MS |
Verify this certificate on Kovera Labs
| Reported test | Result | Stated criterion | Method, where stated |
|---|---|---|---|
| Bacteria (aerobic/anaerobic) | No Growth | — | — |
| Fungi / yeast | Not Detected | — | — |
| Incubation period | 2 days | — | — |
| Temperature | 30-35C | — | — |
| Final determination | SAMPLE PASSES STERILITY SCREEN | — | — |
Evidence reviews and laboratory guides relevant to Tesamorelin 10mg, plus the testing behind each batch.
Explore Tesamorelin research, Australian buying guides and laboratory documentation.
